Kristine Peterson
CIK 1508596 · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$91.7K
Companies
8
Total Filings
60
Lifetime Open-Market Net
-$3.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVBP | Director | — | $29.98 | — | $0 | 3 | 2026-06-22 |
| IMCR | Director | — | $33.51 | — | $0 | 3 | 2026-05-28 |
| ENTA | Director | — | $12.61 | — | $0 | 10 | 2026-03-13 |
| ImmunoGen, Inc. (IMGN) Delisted | Director | 0 | $31.23 | $0 | -$578.0K | 16 | 2024-02-12 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Director | 0 | $2.23 | $0 | $0 | 9 | 2023-09-21 |
| AMRN | Director | 6,000 | $13.95 | $83.7K | -$3.27M | 12 | 2022-06-29 |
| EYPT | Director | 667 | $11.96 | $8.0K | $0 | 4 | 2020-03-03 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 1 | 2017-12-19 |
Recent Filings · Page 3 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-07 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2022-02-18 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2021-06-17 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-16 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2021-03-04 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2021-02-22 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2020-07-15 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-03 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2020-02-28 | ENTA | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.